Cartalax 20mg Peptide – Research Grade

What is Cartalax 20mg?

Cartalax 20mg is a synthetic peptide known in scientific studies as AED or T-31. It contains the amino acid sequence Alanine-Glutamate-Aspartate, derived from the alpha-1 chain of type XI collagen. Researchers classify Cartalax as part of the Khavinson peptides, a group studied for their potential role in regulating biological processes.

Structure and Background

Scientists first identified peptides with similar sequences in kidney extracts rich in polypeptides. Cartalax 20mg, with over 99% purity, is provided in lyophilized powder form. This purity level makes it suitable for controlled laboratory use. Researchers view it as a reliable option when studying cartilage, cellular aging, and inflammatory balance.

Research Applications of Cartalax 20mg

Studies suggest that Cartalax 20mg may show promise in several areas:

• Cartilage and Joint Support – Investigated for its potential role in cartilage regeneration and repair.

• Inflammatory Modulation – Considered for balancing inflammatory activity in tissues.

• Cellular Regulation – Studied as a bioregulator in research related to aging and tissue health.

Why Researchers Select Cartalax 20mg

Researchers prefer Cartalax 20mg because of its specific amino acid sequence, high purity, and consistent quality. Its structure may allow it to influence processes connected to tissue maintenance and cellular function.

Product Information

• Size: 20mg

• Form: Lyophilized powder

• Purity: >99%

• Contents: Cartalax

Conclusion

Cartalax 20mg is a high-quality peptide designed for scientific research. Its unique structure and purity make it suitable for studies exploring cartilage health, inflammation, and cellular activity. Researchers recognize it as a versatile peptide for advanced laboratory investigations.